Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria
Patient representation during the evaluation of medicines by key decision makers such as regulatory agencies, Health Technology Assessment bodies, and healthcare payers is increasingly considered to add value to the appraisals and empowers patients, which means that they gain a more powerful voice o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-08-01
|
| Series: | Medicine Access @ Point of Care |
| Online Access: | https://doi.org/10.1177/2399202619865167 |